Bruchim I - Search Results

1

BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell lines.

Amichay K, Kidron D, Attias-Geva Z, Schayek H, Sarfstein R, Fishman A, Werner H, Bruchim I. Amichay K, et al. Among authors: bruchim i. Int J Gynecol Cancer. 2012 Jun;22(5):748-54. doi: 10.1097/IGC.0b013e318254011f. Int J Gynecol Cancer. 2012. PMID: 22635027

2

Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.

Bruchim I, Kidron D, Amiel A, Altaras M, Fejgin MD. Bruchim I, et al. Gynecol Oncol. 2000 Apr;77(1):197-202. doi: 10.1006/gyno.2000.5733. Gynecol Oncol. 2000. PMID: 10739712 Review.

3

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer.

Bruchim I, Altaras M, Fishman A. Bruchim I, et al. Gynecol Oncol. 2002 Sep;86(3):274-8. doi: 10.1006/gyno.2002.6759. Gynecol Oncol. 2002. PMID: 12217748

4

Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.

Bruchim I, Fishman A, Friedman E, Goldberg I, Chetrit A, Barshack I, Dekel E, Hirsh-Yechezkel G, Modan B, Kopolovic J. Bruchim I, et al. Int J Gynecol Cancer. 2004 Mar-Apr;14(2):251-8. doi: 10.1111/j.1048-891X.2004.014208.x. Int J Gynecol Cancer. 2004. PMID: 15086724

5

Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding.

Bruchim I, Biron-Shental T, Altaras MM, Fishman A, Beyth Y, Tepper R, Aviram R. Bruchim I, et al. J Clin Ultrasound. 2004 Jun;32(5):219-24. doi: 10.1002/jcu.20020. J Clin Ultrasound. 2004. PMID: 15124187 Clinical Trial.

6

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.

Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Gotlieb WH, et al. Among authors: bruchim i. Gynecol Oncol. 2006 Feb;100(2):389-96. doi: 10.1016/j.ygyno.2005.09.048. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300820

7

The insulin-like growth factor-I receptor as an oncogene.

Werner H, Bruchim I. Werner H, et al. Among authors: bruchim i. Arch Physiol Biochem. 2009 May;115(2):58-71. doi: 10.1080/13813450902783106. Arch Physiol Biochem. 2009. PMID: 19485702 Review.

8

Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer.

Shechter-Maor G, Bruchim I, Ben-Harim Z, Altaras M, Fishman A. Shechter-Maor G, et al. Among authors: bruchim i. Int J Gynecol Cancer. 2009 May;19(4):662-4. doi: 10.1111/IGC.0b013e3181a3d626. Int J Gynecol Cancer. 2009. PMID: 19509567

9

Targeting the IGF1 axis in cancer proliferation.

Bruchim I, Attias Z, Werner H. Bruchim I, et al. Expert Opin Ther Targets. 2009 Oct;13(10):1179-92. doi: 10.1517/14728220903201702. Expert Opin Ther Targets. 2009. PMID: 19663648 Review.

10

Sonographic diagnosis of uterine ewing sarcoma.

Tepper R, Bruchim I, Zehavi T, Fishman A, Hershkovitz R. Tepper R, et al. Among authors: bruchim i. J Ultrasound Med. 2009 Dec;28(12):1715-8. doi: 10.7863/jum.2009.28.12.1715. J Ultrasound Med. 2009. PMID: 19933487 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters